RNA mediated trans-activation: its therapeutic potential in anaplastic thyroid cancer

Research output: Contribution to conferenceOtherpeer-review


RNA mediated trans-Activation is a proposed mechanism involved in the setting of the epigenetic state of chromatin. It has been studied first in Drosophila melanogaster where it seems that at least some transcribed loci are marked as transcriptionally active by their own transcripts. This effect acts in trans and in some cases could give rise to a transgenerational paramutational-like effect.This work studies RNA mediated trans-activation in the light of one of its possible applications, specifically its use as a therapeutic strategy for the incurable and highly aggressive ATC (anaplastic thyroid cancer). We explore the possibility to reactivate the Thyroid specific NIS (Natrium-Iodine symport) via the expression of ncRNAs with sequence homology with transcripts from the NIS coding locus itself.This work suggests that RNA trans-activation is a conserved mechanism and it may be used in human to manipulate the gene expression.
Original languageEnglish
Number of pages1
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'RNA mediated trans-activation: its therapeutic potential in anaplastic thyroid cancer'. Together they form a unique fingerprint.

Cite this